Executive Committee
Dr Severin Schwan
Daniel O’Day
Roland Diggelmann
Dr Alan Hippe
Cristina A. Wilbur
Dr Gottlieb Keller
Dr Michael D. Varney
Dr William Pao
Dr Sophie Kornowski-Bonnet
Osamu Nagayama
Dr Stephan Feldhaus
| Name (year of birth) | Position |
|---|---|
| Dr Severin Schwan (1967) | Chief Executive Officer Roche Group |
| Daniel O'Day (1964) | CEO Roche Pharmaceuticals |
| Roland Diggelmann (1967) | CEO Roche Diagnostics |
| Dr Alan Hippe (1967) | Chief Financial and IT Officer |
| Cristina A. Wilbur (1967) | Head of Group Human Resources |
| Dr Gottlieb A. Keller (1954) | General Counsel |
| Enlarged Corporate Executive Committee | |
| Dr Michael D. Varney (1958) | Head of Genentech Research & Early Development (gRED) |
| Dr William Pao (1967) | Head of Roche Pharma Research & Early Development (pRED) |
| Dr Sophie Kornowski-Bonnet (1963) | Head of Roche Partnering |
| Osamu Nagayama (1947) | Chairman and CEO, Chugai |
| Dr Stephan Feldhaus (1962) | Head of Group Communications |
| Secretary to the Corporate Executive Committee | |
| Per-Olof Attinger (1960) | |
Former Members of the Corporate Executive Committee
Last update: 12 April 2018
About the Executive Committee
Roche’s executive team is the company's senior management and decision making body. The Executive Committee of Roche, chosen by the Board of Directors, is responsible for the day-to-day business operations.